Selected examples include dendritic cell vaccines, patient-specific autologous tumor cell vaccines, and vaccines targeting various antigens enriched in tumor cells, such as folate receptor alpha, HER2, brachyury, insulin-like growth factor binding protein-2, survivin, and carcinoembryonic antigen. The gene discussed is BIRC5; the disease is neoplasm.